(Date:12/2/2009)...ple who smoke their first cigarette within minutes...ne, a by-product of nicotine when processed by the... the number of cigarettes smoked. , "Since co...ancer, our results suggest that smokers who smoke ... for lung cancer," said researcher Joshua E. Musca...
(Date:12/2/2009)...osure to secondhand smoke for a prolonged period o...of breast cancer, even in women who never smoked c...r exposure to side-stream smoke could increase ris...d Peggy Reynolds, Ph.D., senior research scientist...ey office. "While no single epidemiologic study ca...
(Date:12/2/2009)...╤ A Smoky Mountain forest,s woodland herb po... how forest understories recover from logging, acc...heavy logging in portions of the forest nearly 80 ...the secondary forest floor was similar to that of ...tant professor of forestry and natural resources, ...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Study finds logging effects vary based on a forest's history, climate 2Oxygen Biotherapeutics Inc Announces Closing of Offer to Acquire Warrants 52154 1Oxygen Biotherapeutics Inc Announces Closing of Offer to Acquire Warrants 52154 2Oxygen Biotherapeutics Inc Announces Closing of Offer to Acquire Warrants 52154 3NewLink Genetics Corporation Closes 247 5 Million Financing 13102 1OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 1OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 2OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 3(Date:12/3/2009)... , DALLAS, Dec. 3 ...rd: ACCP), today provided an update on its Europea...atment for oral mucositis, a debilitating side eff...d is commercially launched by Access, partner, Spe..., Germany, Italy, Norway, Greece and Sweden. Acces...
(Date:12/3/2009)..., TUSTIN, Calif., Dec. 3 /PRNewswire-FirstCall/... ) today announced that it will release its financ...2010 on December 10, 2009 at 7:00 a.m. EST and wil...e results at 11:30 a.m. EST on the same day. ,,...ial results for the second quarter ended October 3...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRNewswire-...ce Officer at Shenzhen Beike Biotechnology Co. Ltd...ference on High-Risk Diabetic,Foot Care in New Del...ding,stem cell research and regenerative medicine ...he Indian Podiatry Association (IPA), aimed,to hel...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Neurostimul.../www.reportlinker.com/p0164232/Neurostimulation---... neurostimulation market stands enthused by the gr...rise in age-related diseases such as, Parkinson,s,...
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6...c. (NYSE Alternext US: IMM.BC) today announced tha...ding (MOU) confirming its interest in exploring th... Pharmaceutical Group Co. Ltd. (BPGC). The MOU co...f collaborative global business development opport...est state-owned pharmaceutical and medical device ...
... million in Q4 2007 - a 4.0% increase , , Q4 200...n Q4 2007 - a 10.0% increase , , Q4 2008 New Book... - a 15.1% increase , , 2008 Net Revenues -- $133...rease , , 2008 Diluted Net Income per Share of $0... New Bookings of $187.2 million vs. $138.6 million...
... (NYSE: LMT ) has partnered with Penn State Uni...nergy sector. As part of the corporation,s commitm...s, Lockheed Martin will fund $400,000 of research ..., , Leveraging a partnership spanning more than 3... collaboration will focus on Smart Grid technolog...
Other Biology Technology:Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance 2Immtech and Beijing Pharmaceutical Group Co. Sign Memorandum of Understanding to Explore Developing Strategic Business Alliance 3ERT Reports Fourth Quarter and Full Year 2008 Results 2ERT Reports Fourth Quarter and Full Year 2008 Results 3ERT Reports Fourth Quarter and Full Year 2008 Results 4ERT Reports Fourth Quarter and Full Year 2008 Results 5ERT Reports Fourth Quarter and Full Year 2008 Results 6ERT Reports Fourth Quarter and Full Year 2008 Results 7ERT Reports Fourth Quarter and Full Year 2008 Results 8ERT Reports Fourth Quarter and Full Year 2008 Results 9ERT Reports Fourth Quarter and Full Year 2008 Results 10ERT Reports Fourth Quarter and Full Year 2008 Results 11Lockheed Martin Invests in Smart Grid Research and Development at Penn State University 2Anti-Human FADD, phospho (Ser194) Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Viral WNV Core Polyclonal Antibody, Unconjugated from ProSci, Inc
Mouse Anti-Human HSD17B3 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Anti-Rad51, N-terminal Antibody, Unconjugated from CHEMICON
Biology Products: